A fast-throughput service for Familial Hypertrophic and Dilated Cardiomyopathy using High resolution melt curve analysis on the Lightscanner

A fast-throughput service for Familial Hypertrophic and Dilated Cardiomyopathy using High resolution melt curve analysis on the Lightscanner

Detaylı Bibliyografya
Asıl Yazarlar:	Thistleton, J, Thomson, K, Wilson, M, Livesey, K, McKinney, J, Blair, E, Watkins, H, Seller, A
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2007

Benzer Materyaller

Oxford Molecular Genetics Laboratory Cardiomyopathy Service
Yazar:: Thistleton, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Evaluation of Clinical Diagnostic Potential of Next Generation Sequencing using Hypertrophic Cardiomyopathy as a Model
Yazar:: Taylor, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2003)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
Yazar:: Suttie, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
Yazar:: Rayner, JJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
Yazar:: Hamza El Hadi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
Yazar:: Seitaro Nomura, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
Yazar:: Enrica Chiti, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
Yazar:: Gehan Abd El-Rahman El-Zarea, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

Dilated cardiomyopathy and the desmin gene.
Yazar:: Mayosi, B, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Yazar:: Megan J. Puckelwartz, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Linked genetic modifiers in hypertrophic cardiomyopathy
Yazar:: Ektisham, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Expansion of a diagnostic service for hypertrophic cardiomyopathy using next generation sequencing
Yazar:: Reid, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
Yazar:: Robinson, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Mutant Allele Amplification Bias Using Rapid Cycle-Real Time PCR and Hi-Res Melting® with LunaProbes™ on the LightScanner® 32
Yazar:: Idaho Technology Inc.
Baskı/Yayın Bilgisi: (2008-11-01)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
Yazar:: Borovikov, I, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
Yazar:: Paradossi Umberto, ve diğerleri
Baskı/Yayın Bilgisi: (2008-12-01)

Sudden death in hypertrophic cardiomyopathy.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2000)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses
Yazar:: Toshiki Kuno, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Myocardial dysfunction in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
Yazar:: Hudsmith, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
Yazar:: Dass, S
Baskı/Yayın Bilgisi: (2012)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
Yazar:: Tadros, R, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Yazar:: Robinson, P, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Impact of angiotensin I converting enzyme insertion/deletion polymorphisms on dilated cardiomyopathy and hypertrophic cardiomyopathy risk.
Yazar:: Jianmin Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)